Radiotherapy and immunotherapy combinations for cancer treatment: past, present and future-Reference-Cited by-同舟云学术

Radiotherapy and immunotherapy combinations for cancer treatment: past, present and future

Published:2024-01-25 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Formenti Silvia¹,Karam Sana²,Herrera Fernanda³^ORCID,Demaria Sandra¹,Deutsch Eric⁴⁵⁶

Affiliation:

1. Weill Cornell Medicine

2. University of Colorado Denver

3. University of Lausanne

4. Inserm

5. Institut Gustave Roussy

6. University of Paris-Saclay

Abstract

While several preclinical studies have outlined the potential of radiotherapy and immunotherapy combinations for cancer treatment, their clinical implementation remains a challenge, with limited clinical benefit reported so far. In this webinar, our panelists will discuss recent developments and persisting challenges in this exciting field from a clinical and translational perspective. The webinar will be hosted by [Nature Communications](https://www.nature.com/ncomms/) editors in collaborations with ImmunoRad. Nature Communications and ImmunoRad declare no (financial and non-) competing interests in the organization of this event.

Publisher

Cassyni

Reference4 articles.

1. Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

2. Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy

3. Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy

4. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study